Philadelphia, Pennsylvania
Cancer observational studies in Philadelphia, PA
38 cancer observational studies are recruiting participants at sites in Philadelphia as of November 18, 2026, according to ClinicalTrials.gov. Oncology Clinical Study can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Philadelphia at a glance
- 38 studies are recruiting at a site in Philadelphia.
- By phase: Observational (38).
- By sponsor: university, hospital or other (31), industry (7).
- By research area: Breast Cancer (14), Lung Cancer (7), Lymphoma (7), Pancreatic Cancer (5), Prostate Cancer (4), Melanoma (1).
- Most recent update to one of these records: November 6, 2026.
Breast cancer studies recruiting in Philadelphia
Basic details from each study's public record (the 30 most recently updated of 38). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University of California, San Francisco
- Study site
- Abramson Cancer Center
- Registry record
- NCT05964504 · updated
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Guardant Health, Inc.
- Study site
- University of Pennsylvania
- Registry record
- NCT05059444 · updated
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
- Observational
- Ages 18 to 90
- Female participants
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Study site
- University of Pennsylvania
- Registry record
- NCT06888388 · updated
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- Abramson Cancer Center of the University of Pennsylvania
- Registry record
- NCT06551116 · updated
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
- Observational
- Ages 25 and older
- Female participants
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Abramson Cancer Center at University of Pennsylvania Medical Center (Data Collection Only)
- Registry record
- NCT03396341 · updated
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
- Observational
- Ages 18 and older
- Female participants
- Sponsor
- SpotitEarly
- Study site
- Hospital of the University of Pennsylvania
- Registry record
- NCT07038785 · updated
B.Brilliant Revelation Comparision Study
- Observational
- Ages 18 and older
- Female participants
- Sponsor
- University of Pennsylvania
- Study site
- Pennsylvania Hospital, Center for Breast Imaging
- Registry record
- NCT07067788 · updated
The PREDICT Registry:
- Observational
- Ages 30 to 85
- Female participants
- Sponsor
- PreludeDx
- Study site
- Sidney Kimmel Comprehensive Cancer Ctr - Jefferson
- Registry record
- NCT03448926 · updated
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
- Observational
- Ages 18 and older
- Female participants
- Sponsor
- Thomas Jefferson University
- Study site
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Registry record
- NCT07478016 · updated
Safe and Explainable AI
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- Hospital of the University of Pennsylvania
- Registry record
- NCT06694181 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Lung cancer studies recruiting in Philadelphia
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Abramson Cancer Center of the University of Pennsylvania ( Site 0010)
- Registry record
- NCT04165798 · updated
Lung Cancer Detection in Never Smokers Using Urine Volatile Organic Compound (VOCs)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Thomas Jefferson University
- Study site
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Registry record
- NCT07871656 · updated
DESTINY-PANTUMOUR04
- Observational
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07124000 · updated
A Registry for People With Lung Cancer
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Thomas Jefferson University Hospital (Data Collection Only)
- Registry record
- NCT06424327 · updated
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
- Observational
- Ages 50 to 80
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Study site
- Thomas Jefferson University
- Registry record
- NCT06974981 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
- Observational
- Ages 18 and older
- Male participants
- Sponsor
- Thomas Jefferson University
- Study site
- Sidney Kimmel Cancer Center at Thomas Jefferson University
- Registry record
- NCT05627219 · updated
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Observational
- Ages 21 and older
- Male participants
- Sponsor
- Prostate Cancer Clinical Trials Consortium
- Study site
- Fox Chase Cancer Center - Temple Health
- Registry record
- NCT03151629 · updated
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- Observational
- Ages 40 and older
- Male participants
- Sponsor
- University of Washington
- Study site
- University of Pennsylvania/Abramson Cancer Center
- Registry record
- NCT04472338 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Melanoma studies recruiting in Philadelphia
Project: Every Child for Younger Patients With Cancer
- Observational
- Up to age 25
- All sexes
- Sponsor
- Children's Oncology Group
- Study sites
- Children's Hospital of Philadelphia · Drexel University School of Medicine · Saint Christopher's Hospital for Children
- Registry record
- NCT02402244 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Lymphoma studies recruiting in Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Observational
- Ages 0 to 38
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Children's Hospital of Philadelphia
- Registry record
- NCT06131801 · updated
Blinatumomab Consolidation in Real World
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Medical College of Wisconsin
- Study site
- University of Pennsylvania
- Registry record
- NCT07117136 · updated
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Observational
- From 4 weeks, up to 18 years
- All sexes
- Sponsor
- University of Pennsylvania
- Study site
- Children's Hospital of Philadelphia
- Registry record
- NCT06529575 · updated
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Observational
- Ages 7 and older
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Children's Hospital of Philadelphia
- Registry record
- NCT05705531 · updated
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Observational
- All ages
- All sexes
- Sponsor
- Center for International Blood and Marrow Transplant Research
- Study site
- Children's Hospital of Philadelphia
- Registry record
- NCT01351545 · updated
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Observational
- All ages
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Saint Christopher's Hospital for Children
- Registry record
- NCT01790152 · updated
A Global Study of the PETAL Consortium
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- University of Pennsylvania
- Registry record
- NCT06067347 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Philadelphia
Pancreatic Cancer Early Detection Consortium
- Observational
- Ages 18 to 90
- All sexes
- Sponsor
- Arbor Research Collaborative for Health
- Study sites
- Fox Chase Cancer Center · University of Pennsylvania
- Registry record
- NCT04970056 · updated
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Observational
- Up to age 17
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- Children's Hospital of Philadelphia
- Registry record
- NCT06651580 · updated
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Observational
- Ages 50 to 75
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study sites
- Fox Chase Cancer Center · Thomas Jefferson University Hospital · University of Pennsylvania/Abramson Cancer Center
- Registry record
- NCT04239573 · updated
Collection of Circulating Biomarkers in Pancreatic Cancer
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- Abramson Cancer Center at University of Pennsylvania
- Registry record
- NCT05743049 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Ask about studies near Philadelphia
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Pennsylvania
All Pennsylvania locations
71 studies recruiting across 36 cities.
Pittsburgh
31 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are observational, meaning researchers follow participants without assigning anything to test, as each study is coded in the registry.
Oncology Clinical Study does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections